Althea (ASX:AGH) share price jumps 9% on cannabis drinks news

A new partnership will see Althea's subsidiary developing cannabis-infused drinks for The Boston Beer Company.

| More on:
A white cannabis leaf set against a green background with a graph going up, indicating a rising share price for ASX cannabis shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Althea Group Holdings Ltd (ASX: AGH) share price is soaring today following news the company will soon be producing cannabis-infused drinks.

A subsidiary of Althea has entered into agreements with Boston Beer Company Inc (NYSE: SAM) to develop beverages.

Right now, the Althea share price is 26 cents, 8.51% higher than its previous close.

Let's take a closer look at the intriguing news from the medical cannabis producer and supplier.

Is green the new gold?

The Althea share price is gaining following news its subsidiary, Peak Processing Solutions, will be infusing drinks with cannabis.

Peak will work with The Boston Beer Company's subsidiary BBCCC to produce the non-alcoholic beverages. It will use cannabis from WeedMD Rx Inc, a subsidiary of Entourage Health Corp. The drinks will then be sold in Canada.

Under the agreement, BBCCC will provide Peak with US$2 million of funding to research and develop the products.

Peak will also receive a minimum of US$285,000 each year. Additionally, it will become the exclusive manufacturer of all cannabis beverages produced or sold in Canada under BBC branding for the duration of the 5-year agreement.

Entourage will supply all cannabis materials Peak needs to make the beverages and will buy the resulting products from Peak.

According to Althea, infused-cannabis beverage sales are growing and Peak has positioned itself as the leading producer in the category. Althea pointed to a recent report by Million Insights which estimated the cannabis beverage market will be worth US$2.8 billion in 2025.

Commentary from management

Althea's CEO, Josh Fegan, commented on the news driving the company's share price today, saying:

This project is further validation of Peak's significant and unique capabilities in the recreational cannabis industry and the latest in a growing list of deals Peak has signed with high quality customers, including seven North American publicly listed companies. AGH is very optimistic about the cannabis-infused beverage category and Peak remains well positioned to capitalise on the recreational cannabis boom in general.

BBCCC's head of cannabis, Paul Weaver, added:

Peak has built a world class facility in Canada, with the right staff and systems in place to ensure every drink is prepared with the highest care and excellence. WeedMD is one of Canada's oldest and most respected regulated cannabis cultivators. Their unwavering commitment to quality is exactly what we look for in our partners.

Finally, Entourage's CEO and chair, George Scorsis, stated:

[O]ur collective industry expertise together with Entourage's cannabis research and advanced branding strategies will establish our product portfolio with another unique offering. In addition, this provides an opportunity to further explore our collective reach into international markets.

Althea share price snapshot

Despite being in the green today, the Althea share price has been struggling recently.

It has fallen 42% year to date. It is also currently 32% lower than it was this time last year.  

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Cannabis Shares

Man in the green house growing medical cannabis
Cannabis Shares

ASX cannabis stocks eyeing $1 billion domestic market

Legal cannabis use is soaring in Australia.

Read more »

two men in formal business clothing closely inspect a bud from a cannabis crop.
Cannabis Shares

2 ASX cannabis shares with big news today

What's going on with these pot stocks today? Let's find out.

Read more »

A man in a horse head mask and suit jumps for joy on a beach.
Cannabis Shares

Could ASX cannabis shares be set for a smoking hot rebound?

ASX cannabis stocks could be set for a strong finish to 2024.

Read more »

Man in a cannabis greenhouse looks unhappy and puts his thumb down.
Cannabis Shares

Why are these 2 ASX cannabis stocks sputtering today?

Up 174% in 2023, this ASX cannabis share is giving back some more of its gains today.

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Cannabis Shares

Guess which ASX cannabis share is crashing 36% following an FDA blow

Rookie mistake: This cannabis share just missed out on FDA approval for a simple reason.

Read more »

A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
Cannabis Shares

Could ASX cannabis shares be set for a resurgence?

The world's legal and medical fraternities are taking small steps forward in the medicinal cannabis movement.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Cannabis Shares

This ASX cannabis stock is up 160% since June, and it has an FDA ruling coming up!

Investors are very excited about this cannabis stock.

Read more »

two men in formal business clothing closely inspect a bud from a cannabis crop.
Cannabis Shares

Why ASX cannabis shares just jumped back into the spotlight

ASX cannabis shares operate in a nation where medical marijuana is legal but recreational use remains broadly forbidden.

Read more »